• 2790 Citations
  • 29 h-Index
If you made any changes in Pure these will be visible here soon.

Personal profile


  • 國立成功大學臨醫所博士

Research Interests

  • 血液疾病
  • 腫瘤治療
  • 腸胃道腫瘤治療
  • 頭頸癌治療

Fingerprint Dive into the research topics where Chia-Jui Yen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 80 Similar Profiles
Hepatocellular Carcinoma Medicine & Life Sciences
Head and Neck Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Hepatitis B virus Medicine & Life Sciences
Survival Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Placebos Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2004 2018

Research Output 2004 2020

A selective Aurora-A 5′-UTR siRNA inhibits tumor growth and metastasis

Lai, C. H., Chen, R. Y., Hsieh, H. P., Tsai, S. J., Chang, K. C., Yen, C. J., Huang, Y. C., Liu, Y. W., Lee, J. C., Lai, Y. C., Hung, L. Y. & Lin, B. W., 2020 Mar 1, In : Cancer Letters. 472, p. 97-107 11 p.

Research output: Contribution to journalArticle

5' Untranslated Regions
Small Interfering RNA
Neoplasm Metastasis
4 Citations (Scopus)

A nationwide survey of adherence to analgesic drugs among cancer patients in Taiwan: prevalence, determinants, and impact on quality of life

Chou, W. C., Chen, J. S., Hung, C. Y., Lu, C. H., Shao, Y. Y., Chiou, T. J., Sung, Y. C., Rau, K. M., Yen, C-J., Yeh, S. P., Liu, T. C., Wu, M. F., Lee, M. Y., Yu, M. S., Hwang, W. L., Lai, P. Y., Chang, C. S. & Hsieh, R. K., 2019 Aug 1, In : Supportive Care in Cancer. 27, 8, p. 2857-2867 11 p.

Research output: Contribution to journalArticle

Quality of Life

A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma

Qin, S., Chan, S. L., Sukeepaisarnjaroen, W., Han, G., Choo, S. P., Sriuranpong, V., Pan, H., Yau, T., Guo, Y., Chen, M., Ren, Z., Xu, J., Yen, C. J., Lin, Z. Z., Manenti, L., Gu, Y., Sun, Y., Tiedt, R., Hao, L., Song, W. & 1 others, Tanwandee, T., 2019 Jan 1, In : Therapeutic Advances in Medical Oncology. 11

Research output: Contribution to journalArticle

Open Access
Hepatocellular Carcinoma
Logistic Models
2 Citations (Scopus)

CPAP promotes angiogenesis and metastasis by enhancing STAT3 activity

Chen, R. Y., Yen, C. J., Liu, Y. W., Guo, C. G., Weng, C. Y., Lai, C. H., Wang, Y. M., Lin, Y. J. & Hung, L. Y., 2019 Jan 1, (Accepted/In press) In : Cell Death and Differentiation.

Research output: Contribution to journalArticle

Neoplasm Metastasis
Hepatocellular Carcinoma

Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma

Lu, L. C., Hsu, C., Shao, Y. Y., Chao, Y., Yen, C. J., Shih, I. L., Hung, Y. P., Chang, C. J., Shen, Y. C., Guo, J. C., Liu, T. H., Hsu, C. H. & Cheng, A. L., 2019 Nov 1, In : Liver Cancer. 8, 6, p. 480-490 11 p.

Research output: Contribution to journalArticle

Open Access
Hepatocellular Carcinoma
Monoclonal Antibodies


The clinical significances and regulatory mechanisms of IGF2 mRNA-binding protein 3 (IGF2BP3) in hepatocellular carcinoma

Author: 彥妤, 劉., 2018 Aug 15

Supervisor: Yen, C. (Supervisor)

Student thesis: Master's Thesis